Dipyridamole intervention of breast cell carcinogenesis

Molecular Carcinogenesis

Volumn 53, Issue 3, 2014, Pages 243-252

  Choudhary, Shambhunath ^a   Sood, Shilpa ^a   Wang, Hwa Chain Robert ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Breast cancer; Chemoprevention; Environmental carcinogens; Reactive oxygen species

Indexed keywords

BREAST CANCER; CHEMOPREVENTION; ENVIRONMENTAL CARCINOGENS; REACTIVE OXYGEN SPECIES;

APOPTOSIS; BENZO(A)PYRENE; BLOTTING, WESTERN; BREAST; BREAST NEOPLASMS; CARCINOGENS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; DIPYRIDAMOLE; DNA DAMAGE; FEMALE; HUMANS; IMIDAZOLES; MAP KINASE SIGNALING SYSTEM; NITROSAMINES; REACTIVE OXYGEN SPECIES; VASODILATOR AGENTS;

EID: 84894285462     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.21970     Document Type: Article

References (57)

1. DeBruin LS, Josephy PD. Perspectives on the chemical etiology of breast cancer. Environ Health Perspect 2002; 110:119-128.
2. American Cancer Society. Cancer Facts & Figures 2012. American Cancer Society, http://www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/cancer-facts-figures-2012
3. Kelloff GJ, Hawk ET, Sigman CC, editors. Cancer chemoprevention: Strategies for cancer chemoprevention. Vol. 2, Totowa, NJ: Human Press; 2005. 517 p.
4. Mei J, Hu H, McEntee M, Plummer H III, Song P, Wang HCR. Transformation of noncancerous human breast epithelial cell MCF10A induced by the tobacco-specific carcinogen NNK. Breast Cancer Res Treat 2003; 79:95-105.
5. Siriwardhana N, Wang HCR. Precancerous carcinogenesis of human breast epithelial cells by chronic exposure to benzo[a]pyrene. Mol Carcinog 2008; 47:338-348.
6. Siriwardhana N, Choudhary S, Wang HCR. Precancerous model of human breast epithelial cells induced by the tobacco-specific carcinogen NNK for prevention. Breast Cancer Res Treat 2008; 109:427-441.
7. Song X, Siriwardhana N, Rathore K, Lin D, Wang HCR. Grape seed proanthocyanidin suppression of breast cell carcinogenesis induced by chronic exposure to combined 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene. Mol Carcinog 2010; 49:450-463.
8. Rathore K, Choudhary S, Odoi A, Wang HCR. Green tea catechin intervention of reactive oxygen species-mediated ERK pathway activation and chronically-induced breast cell carcinogenesis. Carcinogenesis 2012; 33:174-183.
9. Choudhary S, Sood S, Donnell RL, Wang HC. Intervention of human breast cell carcinogenesis chronically induced by 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine. Carcinogenesis 2012; 33:876-885.
10. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70.
11. Reddig PJ, Juliano RL. Clinging to life: Cell to matrix adhesion and cell survival. Cancer Metastasis Rev 2005; 24:425-439.
12. Debnath J, Brugge JS. Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer 2005; 5:675-688.
13. Preston-Martin S, Pike MC, Ross RK, Henderson BE. Epidemiologic evidence for the increased cell proliferation model of carcinogenesis. Prog Clin Biol Res 1993; 369:21-34.
14. Charafe-Jauffret E, Monville F, Ginestier C, Dontu G, Birnbaum D, Wicha MS. Cancer stem cells in breast: Current opinion and future challenges. Pathobiology 2008; 75:75-84.
15. Dontu G, Abdallah WM, Foley JM, et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003; 17:1253-1270.
16. Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1:555-567.
17. Hand PH, Vilasi V, Thor A, Ohuchi N, Schlom J. Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas. J Natl Cancer Inst 1987; 79:59-65.
18. Pethe V, Shekhar PV. Estrogen inducibility of c-Ha-ras transcription in breast cancer cells. Identification of functional estrogen-responsive transcriptional regulatory elements in exon 1/intron 1 of the c-Ha-ras gene. J Biol Chem 1999; 274:30969-30978.
19. Santen RJ, Song RX, McPherson R, et al. The role of mitogen-activated protein (MAP) kinase in breast cancer. J Steroid Biochem Mol Biol 2002; 80:239-256.
20. Desouki MM, Kulawiec M, Bansal S, Das GM, Singh KK. Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors. Cancer Biol Ther 2005; 4:1367-1373.
21. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol Rev 2007; 87:245-313.
22. Suh YA, Arnold RS, Lassegue B, et al. Cell transformation by the superoxide-generating oxidase Mox1. Nature 1999; 401:79-82.
23. Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: Mechanisms, mutation, and disease. FASEB J 2003; 17:1195-1214.
24. Pala V, Krogh V, Berrino F, et al. Meat, eggs, dairy products, and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Am J Clin Nutr 2009; 90:602-612.
25. Zheng W, Lee SA. Well-done meat intake, heterocyclic amine exposure, and cancer risk. Nutr Cancer 2009; 61:437-446.
26. Sugimura T, Wakabayashi K, Nakagama H, Nagao M. Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish. Cancer Sci 2004; 95:290-299.
27. Zheng W, Gustafson DR, Sinha R, et al. Well-done meat intake and the risk of breast cancer. J Natl Cancer Inst 1998; 90:1724-1729.
28. Sinha R, Gustafson DR, Kulldorff M, Wen W-Q, Cerhan JR, Zheng W. 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine, a carcinogen in high-temperature-cooked meat, and breast cancer risk. J Natl Cancer Inst 2000; 92:1352-1354.
29. Hecht SS. Tobacco smoke carcinogens and breast cancer. Environ Mol Mutagen 2002; 39:119-126.
30. Besaratinia A, Maas LM, Brouwer EM, et al. A molecular dosimetry approach to assess human exposure to environmental tobacco smoke in pubs. Carcinogenesis 2002; 23:1171-1176.
31. Cavalieri E, Rogan E, Sinha D. Carcinogenicity of aromatic hydrocarbons directly applied to rat mammary gland. J Cancer Res Clin Oncol 1988; 114:3-9.
32. Li D, Zhang W, Sahin AA, Hittelman WN. DNA adducts in normal tissue adjacent to breast cancer: A review. Cancer Detect Prev 1999; 23:454-462.
33. Rundle A, Tang D, Hibshoosh H, et al. The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer. Carcinogenesis 2000; 21:1281-1289.
34. Rubin H. Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: A bio-historical perspective with updates. Carcinogenesis 2011; 22:1903-1930.
35. Hecht SS. Recent studies on mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco specific lung carcinogen. Crit Rev Toxicol 1996; 26:163-181.
36. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999; 91:1194-1210.
37. Chhabra SK, Anderson LM, Perella C, et al. Coexposure to ethanol with N-nitrosodimethylamine or 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone during lactation of rats: Marked increase in O(6)-methylguanine-DNA adducts in maternal mammary gland and in suckling lung and kidney. Toxicol Appl Pharmacol 2000; 169:191-200.
38. Ohnishi T, Fukamachi K, Ohshima Y, et al. Possible application of human c-Ha-ras proto-oncogene transgenic rats in a medium-term bioassay model for carcinogens. Toxicol Pathol 2007; 35:436-443.
39. Kim HH, Liao JK. Translational therapeutics of dipyridamole. Arterioscler Thromb Vasc Biol 2008; 28:39-42.
40. Qin T, Qin F, Li N, Lu S, Liu W, Li F. Quantitative determination of dipyridamole in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study. Biomed Chromatogr 2010; 24:268-273.
41. Iuliano L, Violi F, Ghiselli A, Alessandri C, Balsano F. Dipyridamole inhibits lipid peroxydation and scavenges oxygen radicals. Lipids 1989; 24:430-433.
42. Iuliano L, Pratico D, Ghiselli A, Bonavita MS, Violi F. Reaction of dipyridamole with the hydroxyl radical. Lipids 1992; 27:349-353.
43. Jekunen A, Vick J, Sanga R, Chan TC, Howell SB. Synergism between dipyridamole and cisplatin in human ovarian carcinoma cells in vitro. Cancer Res 1992; 52:3566-3571.
44. Kusumoto H, Maehara Y, Anai H, Kusumoto T, Sugimachi K. Potentiation of adriamycin cytotoxicity by dipyridamole against HeLa cells in vitro and sarcoma 180 cells in vivo. Cancer Res 1988; 48:1208-1212.
45. Grem JL, Fischer PH. Augmentation of 5-fluorouracil cytotoxicity in human colon cancer cells by dipyridamole. Cancer Res 1985; 45:2967-2972.
46. Willson JK, Fischer PH, Tutsch K, et al. Phase I clinical trial of a combination of dipyridamole and acivicin based upon inhibition of nucleoside salvage. Cancer Res 1988; 48:5585-5590.
47. Budd GT, Jayaraj A, Grabowski D, et al. Phase I trial of dipyridamole with 5-fluorouracil and folinic acid. Cancer Res 1990; 50:7206-7211.
48. Tzanakakis GN, Agarwal KC, Vezeridis MP. Prevention of human pancreatic cancer cell-induced hepatic metastasis in nude mice by dipyridamole and its analog RA-233. Cancer 1993; 71:2466-2471.
49. Sakaguchi Y, Emi Y, Maehara Y, Kohnoe S, Sugimachi K. Combined treatment of adriamycin and dipyridamole inhibits lung metastasis of B16 melanoma cells in mice. Eur Surg Res 1990; 22:213-218.
50. Keane TE, Rosner GL, Gingrich JR, Poulton SH, Walther PJ. The therapeutic impact of dipyridamole: Chemopotentiation of the cytotoxic combination 5-fluorouracil/cisplatin in an animal model of human bladder cancer. J Urol 1991; 146:1418-1424.
51. Choudhary S, Wang HCR. Proapoptotic ability of oncogenic H-Ras to facilitate apoptosis induced by histone deacetylase inhibitors in human cancer cells. Mol Cancer Ther 2007; 6:1099-1111.
52. Choudhary S, Rathore K, Wang HCR. FK228 and oncogenic H-Ras synergistically induce Mek1/2 and Nox-1 to generate reactive oxygen species for differential cell death. Anticancer Drugs 2010; 21:831-840.
53. Olive PL, Banáth JP. The comet assay: A method to measure DNA damage in individual cells. Nat Protoc 2006; 1:23-29.
54. Hung KY, Chen CT, Huang JW, Lee PH, Tsai TJ, Hsieh BS. Dipyridamole inhibits TGF-beta-induced collagen gene expression in human peritoneal mesothelial cells. Kidney Int 2001; 60:1249-1257.
55. Hung KY, Chen CT, Yen CJ, Lee PH, Tsai TJ, Hsieh BS. Dipyridamole inhibits PDGF-stimulated human peritoneal mesothelial cell proliferation. Kidney Int 2001; 60:872-881.
56. Clark GJ, Der CJ. Aberrant function of the Ras signal transduction pathway in human breast cancer. Breast Cancer Res Treat 1995; 35:133-144.
57. Malins DC, Polissar NL, Gunselman SJ. Progression of human breast cancers to the metastatic state is linked to hydroxyl radical-induced DNA damage. Proc Natl Acad Sci USA 1996; 93:2557-2563.